Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Trident Lifeline's EBIT per Share for the
three
months ended in Jun. 2026 was ₹6.33.
Its EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 was ₹28.87.
During the past 12 months, the average EBIT per Share Growth Rate of Trident Lifeline was 87.10% per year.
During the past 3 years, the average EBIT per Share Growth Rate was 43.30% per year.
During the past 5 years, the average EBIT per Share Growth Rate was 71.40% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.
The historical rank and industry rank for Trident Lifeline's EBIT per Share or its related term are showing as below:
BOM:543616'
s 3-Year EBIT Growth Rate Range Over the Past 10 Years
Min: 43.3 Med: 53.4 Max: 95.9
Current: 43.3
During the past 7 years, the highest 3-Year average EBIT per Share Growth Rate of Trident Lifeline was 95.90% per year. The lowest was 43.30% per year. And the median was 53.40% per year.
BOM:543616's 3-Year EBIT Growth Rate is ranked better than 83.11% of 521
companies
in the Healthcare Providers & Services industry
Industry Median: 11.5
vs BOM:543616: 43.30
Trident Lifeline (BOM:543616) EBIT per Share Explanation
EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.
Trident Lifeline EBIT per Share Related Terms
Trident Lifeline EBIT per Share Historical Data
* Premium members only.
The historical data trend for Trident Lifeline's EBIT per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
EBIT per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹28.87
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Trident Lifeline (BOM:543616) has a EBIT per Share of ₹28.87 as of Jun. 2026. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Trident Lifeline and its competitors. According to the industry distribution chart, Trident Lifeline ranks #88 out of 521 companies in the Healthcare Providers & Services industry, placing it in the top 16.9%.
Is Trident Lifeline's EBIT per Share too high?
Trident Lifeline's current EBIT per Share is ₹28.87. Based on the distribution chart, Trident Lifeline ranks #88 out of 521 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Trident Lifeline has a GF Score™ of 83/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Trident Lifeline's EBIT per Share compare to competitors?
According to the Healthcare Providers & Services industry distribution chart, Trident Lifeline ranks #88 out of 521 companies for EBIT per Share. This places Trident Lifeline in the top 17% of its industry — outperforming the majority of peers. The industry median EBIT per Share is 11.50. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBIT per Share for a Healthcare Providers & Services company?
The median EBIT per Share among Healthcare Providers & Services companies is 11.50, based on 521 companies in the industry. Companies in the top quartile (top 25%) have a EBIT per Share significantly above this median, while those in the bottom quartile fall well below. However, EBIT per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBIT per Share mean?
A high EBIT per Share can signal that a stock is expensive relative to its fundamentals. EBIT per Share is the amount of Earnings Before Interest and Taxes per outstanding share of the company's stock. View historical data on Trident Lifeline and its competitors. For the Healthcare Providers & Services industry, the median EBIT per Share is 11.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Trident Lifeline's current EBIT per Share is ₹28.87. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Trident Lifeline stock overvalued right now?
Based on GuruFocus' analysis, Trident Lifeline (BOM:543616) is currently considered Possible Value Trap. The stock's GF Value™ is ₹610.19, compared to a current price of ₹283.65 — trading 53.5% below its estimated fair value. The current EBIT per Share is ₹28.87. Trident Lifeline's overall GF Score™ is 83/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBIT per Share calculated?
EBIT per Share is calculated from a company's financial statements. For Trident Lifeline (BOM:543616), the current EBIT per Share is ₹28.87 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Trident Lifeline (BOM:543616) Overvalued in 2026?
Based on GuruFocus' analysis, Trident Lifeline stock appears to be undervalued.
The current stock price of ₹283.65 is trading 53.5% below its estimated GF Value™ of ₹610.19.
GuruFocus considers Trident Lifeline to be Possible Value Trap.
Key valuation signals for BOM:543616:
EBIT per Share: ₹28.87
GF Value™: ₹610.19 vs. price of ₹283.65 (53.5% below fair value)
No single metric tells the full story. See the BOM:543616 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Trident Lifeline Ltd is engaged in the marketing of pharmaceutical products in domestic as well as international market. The company is also engaged in distribution of pharmaceutical products through third-party distribution network. It also offers a wide range of pharmaceutical formulations and products manufactured on contract manufacturing under a loan license. The Company's reportable geographical segments include India, Ghana, Kenya, Peru, Cameroon, Venezuela, and the Rest of World.
83GF Score
Get the complete analysis for BOM:543616
EBIT per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:543616 has been successfully added to your 
